Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer.

Luciana PuleoLaura AgateIrene BargelliniGiuseppe BoniPaolo PiaggiClaudio TrainoTommaso DepaloGiulia LorenzoniFrancesca BianchiDuccio VolterraniSandra BrogioniValeria BotticiMaurizia Rossana BrunettoBarbara CocoEleonora MolinaroRossella Elisei

Published in: European thyroid journal (2022)

TARE is effective in LM treatment of MTC. The absence of severe complications and the good tolerability make TARE a valid therapeutic strategy when liver LM are multiple and progressive.

Keyphrases

liver metastases
multiple sclerosis
open label
early onset
risk factors
clinical trial
double blind
replacement therapy